NTRA
Natera, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$369.39
+0.84%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.22
- Revenue estimate
- $707.9M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.47
- EPS estimate
- -$0.49
- Revenue actual
- $752.8M
- Revenue estimate
- $661.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -21.7%
- Revenue beats (12Q)
- 11
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $343
- PT range
- $260 – $435
- Analysts
- 16
15 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.49 | -$0.47 | Beat 4.85% | $752.8M |
| May 7, 2026 | -$0.53 | -$0.56 | Miss -5.66% | $696.6M |
| Nov 6, 2025 | -$0.39 | -$0.64 | Miss -65.94% | $592.2M |
| Aug 7, 2025 | -$0.62 | -$0.74 | Miss -20.24% | $546.6M |
| May 8, 2025 | -$0.64 | -$0.50 | Beat 21.93% | $501.8M |
| Feb 27, 2025 | -$0.38 | -$0.41 | Miss -7.57% | $476.1M |
| Aug 8, 2024 | -$0.69 | -$0.30 | Beat 56.52% | $413.4M |
| May 9, 2024 | -$0.71 | -$0.56 | Beat 21.13% | $367.7M |
| Feb 28, 2024 | -$0.73 | -$0.64 | Beat 12.33% | $311.1M |
| Aug 3, 2023 | -$1.09 | -$0.97 | Beat 11.01% | $261.4M |
| Feb 28, 2023 | -$1.42 | -$1.37 | Beat 3.52% | $217.3M |
| Aug 4, 2022 | -$1.50 | -$1.50 | In line | $198.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026